Role of BNP vs NT-proBNP Testing in the Age of New Drug Therapies: Sacubitril-Valsartan

Affiliations

• ¹ Co-Director, Clinical & Forensic Toxicology Laboratory, Hennepin Healthcare/Hennepin County Medical Center, Minneapolis, MN; [email protected].
• ² Cardiac Biomarkers Trials Laboratory, Hennepin Healthcare Research Institute, Minneapolis, MN.
• ³ Professor, Laboratory Medicine & Pathology, University of Minnesota, Minneapolis, MN.
• ⁴ Professor of Medicine, Division of Cardiovascular Medicine; Director, Cardiovascular Intensive Care Unit, University of California, San Diego, CA.
• ⁵ Hutter Family Professor of Medicine, Harvard Medical School, Boston, MA.
• ⁶ Physician, Cardiology Division, Massachusetts General Hospital, Boston, MA.
• ⁷ Cardiometabolic Trials and Trial Design, Baim Institute for Clinical Research, Brookline, MA.
• ⁸ Professor of Medicine, University of Oslo, Oslo, Norway.
• ⁹ Head, Cardio-Thoracic Research Group, Division of Medicine, Akershus University Hospital, Oslo, Norway.
• ¹⁰ Associate Editor, Circulation.
• ¹¹ Senior Consultant, Hospital de Sant Pau, Barcelona, Spain.
• ¹² Professor, Clinical Biochemistry, Universitat Autònoma, Barcelona, Spain.
• ¹³ Professor of Medicine/Cardiology and Professor of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
• ¹⁴ Chair, CCLS Division, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.